Aldolase antibody 38C2 (Aldrich no. 47,995-0) catalyzes the aldol reac
tion between hydroxyacetone and aldehyde 7 to give dihydroxyketone 8 a
lpha in an enantiomeric excess (ee) >99%. This reaction has been perfo
rmed on a semipreparative scale to give the product in 55% yield (ee=9
8%). Aldol 8 alpha can be converted to hydroxybrevicomins ent-5 and en
t-6 by reduction and acid-catalyzed cyclization. Antibody 38C2 also ca
talyzes the retro-aldol reaction of racemic syn-8. After 52% conversio
n, the enantiomeric product (8 beta) is obtained in >99% ee. By using
either antibody-catalyzed aldol or retro-aldol reactions, both aldol e
nantiomers can be prepared with a single antibody catalyst. This metho
dology has been applied in highly enantioselective total syntheses of
ten brevicomins.